0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Infectious Disease Diagnostics Testing - Global Market Insights and Sales Trends 2024
Published Date: December 2023
|
Report Code: QYRE-Othe-2O272
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Infectious Disease Diagnostics Testing Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Infectious Disease Diagnostics Testing - Global Market Insights and Sales Trends 2024

Code: QYRE-Othe-2O272
Report
December 2023
Pages:114
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Infectious Disease Diagnostics Testing - Market Size

The global Infectious Disease Diagnostics Testing market size is expected to reach US$ 21090 million by 2029, growing at a CAGR of 3.5% from 2023 to 2029.

Infectious Disease Diagnostics Testing -  Market

Infectious Disease Diagnostics Testing - Market

In hospitals, infectious disease specialists help ensure the timely diagnosis and treatment of acute infections by recommending the appropriate diagnostic tests to identify the source of the infection and by recommending the appropriate antibiotic to treat the infection.
The market is mainly driven by the significant applications of Infectious Disease Diagnostics Testing in various end use industries. The expanding demands from the Hospital, Academics Research and Others,, are propelling Infectious Disease Diagnostics Testing market. Molecular Diagnostic Test, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the POC Infectious Disease Diagnostics Test segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Infectious Disease Diagnostics Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Infectious Disease Diagnostics Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Infectious Disease Diagnostics Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Infectious Disease Diagnostics Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Infectious Disease Diagnostics Testing covered in this report include Abbott, bioMérieux, Diasorin, Roche Diagnostic, Beckman Coulter, Becton, Dickinson and Company, Bio-Rad Laboratories, Cavidi and Cepheid, etc.
The global Infectious Disease Diagnostics Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott
bioMérieux
Diasorin
Roche Diagnostic
Beckman Coulter
Becton, Dickinson and Company
Bio-Rad Laboratories
Cavidi
Cepheid
Corgenix
Diaxonhit
Eiken Chemical
EMD Millipore
Epitope Diagnostic
EUROIMMUN
Gold Standard Diagnostics
Hologic
Immunetics
InBios International

Scope of Infectious Disease Diagnostics Testing - Market Report

Report Metric Details
Report Name Infectious Disease Diagnostics Testing - Market
Forecasted market size in 2029 US$ 21090 million
CAGR 3.5%
Forecasted years 2023 - 2029
Global Infectious Disease Diagnostics Testing market, by region:
  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Infectious Disease Diagnostics Testing market, Segment by Type:
  • Molecular Diagnostic Test
  • POC Infectious Disease Diagnostics Test
Global Infectious Disease Diagnostics Testing market, by Application
  • Hospital
  • Academics Research
  • Others
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter Four: Detailed analysis of Infectious Disease Diagnostics Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
  • Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
  • Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter Twelve: Research Finding/Conclusion

FAQ for this report

What is the Infectious Disease Diagnostics Testing - Market size in 2029?

Ans: The Infectious Disease Diagnostics Testing - Market size in 2029 will be US$ 21090 million.

What are the Application segmentation covered in the Infectious Disease Diagnostics Testing - Market report?

Ans: The Applications covered in the Infectious Disease Diagnostics Testing - Market report are Hospital, Academics Research, Others

What are the Type segmentation covered in the Infectious Disease Diagnostics Testing - Market report?

Ans: The Types covered in the Infectious Disease Diagnostics Testing - Market report are Molecular Diagnostic Test, POC Infectious Disease Diagnostics Test

1 Market Overview of Infectious Disease Diagnostics Testing
1.1 Infectious Disease Diagnostics Testing Market Overview
1.1.1 Infectious Disease Diagnostics Testing Product Scope
1.1.2 Infectious Disease Diagnostics Testing Market Status and Outlook
1.2 Global Infectious Disease Diagnostics Testing Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Infectious Disease Diagnostics Testing Market Size by Region (2018-2029)
1.4 Global Infectious Disease Diagnostics Testing Historic Market Size by Region (2018-2023)
1.5 Global Infectious Disease Diagnostics Testing Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Infectious Disease Diagnostics Testing Market Size (2018-2029)
1.6.1 North America Infectious Disease Diagnostics Testing Market Size (2018-2029)
1.6.2 Europe Infectious Disease Diagnostics Testing Market Size (2018-2029)
1.6.3 Asia-Pacific Infectious Disease Diagnostics Testing Market Size (2018-2029)
1.6.4 Latin America Infectious Disease Diagnostics Testing Market Size (2018-2029)
1.6.5 Middle East & Africa Infectious Disease Diagnostics Testing Market Size (2018-2029)
2 Infectious Disease Diagnostics Testing Market by Type
2.1 Introduction
2.1.1 Molecular Diagnostic Test
2.1.2 POC Infectious Disease Diagnostics Test
2.2 Global Infectious Disease Diagnostics Testing Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Infectious Disease Diagnostics Testing Historic Market Size by Type (2018-2023)
2.2.2 Global Infectious Disease Diagnostics Testing Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Infectious Disease Diagnostics Testing Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Infectious Disease Diagnostics Testing Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Infectious Disease Diagnostics Testing Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Infectious Disease Diagnostics Testing Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Infectious Disease Diagnostics Testing Revenue Breakdown by Type (2018-2029)
3 Infectious Disease Diagnostics Testing Market Overview by Application
3.1 Introduction
3.1.1 Hospital
3.1.2 Academics Research
3.1.3 Others
3.2 Global Infectious Disease Diagnostics Testing Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Infectious Disease Diagnostics Testing Historic Market Size by Application (2018-2023)
3.2.2 Global Infectious Disease Diagnostics Testing Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Infectious Disease Diagnostics Testing Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Infectious Disease Diagnostics Testing Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Infectious Disease Diagnostics Testing Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Infectious Disease Diagnostics Testing Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Infectious Disease Diagnostics Testing Revenue Breakdown by Application (2018-2029)
4 Infectious Disease Diagnostics Testing Competition Analysis by Players
4.1 Global Infectious Disease Diagnostics Testing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Infectious Disease Diagnostics Testing as of 2022)
4.3 Date of Key Players Enter into Infectious Disease Diagnostics Testing Market
4.4 Global Top Players Infectious Disease Diagnostics Testing Headquarters and Area Served
4.5 Key Players Infectious Disease Diagnostics Testing Product Solution and Service
4.6 Competitive Status
4.6.1 Infectious Disease Diagnostics Testing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott
5.1.1 Abbott Profile
5.1.2 Abbott Main Business
5.1.3 Abbott Infectious Disease Diagnostics Testing Products, Services and Solutions
5.1.4 Abbott Infectious Disease Diagnostics Testing Revenue (US$ Million) & (2018-2023)
5.1.5 Abbott Recent Developments
5.2 bioMérieux
5.2.1 bioMérieux Profile
5.2.2 bioMérieux Main Business
5.2.3 bioMérieux Infectious Disease Diagnostics Testing Products, Services and Solutions
5.2.4 bioMérieux Infectious Disease Diagnostics Testing Revenue (US$ Million) & (2018-2023)
5.2.5 bioMérieux Recent Developments
5.3 Diasorin
5.3.1 Diasorin Profile
5.3.2 Diasorin Main Business
5.3.3 Diasorin Infectious Disease Diagnostics Testing Products, Services and Solutions
5.3.4 Diasorin Infectious Disease Diagnostics Testing Revenue (US$ Million) & (2018-2023)
5.3.5 Roche Diagnostic Recent Developments
5.4 Roche Diagnostic
5.4.1 Roche Diagnostic Profile
5.4.2 Roche Diagnostic Main Business
5.4.3 Roche Diagnostic Infectious Disease Diagnostics Testing Products, Services and Solutions
5.4.4 Roche Diagnostic Infectious Disease Diagnostics Testing Revenue (US$ Million) & (2018-2023)
5.4.5 Roche Diagnostic Recent Developments
5.5 Beckman Coulter
5.5.1 Beckman Coulter Profile
5.5.2 Beckman Coulter Main Business
5.5.3 Beckman Coulter Infectious Disease Diagnostics Testing Products, Services and Solutions
5.5.4 Beckman Coulter Infectious Disease Diagnostics Testing Revenue (US$ Million) & (2018-2023)
5.5.5 Beckman Coulter Recent Developments
5.6 Becton, Dickinson and Company
5.6.1 Becton, Dickinson and Company Profile
5.6.2 Becton, Dickinson and Company Main Business
5.6.3 Becton, Dickinson and Company Infectious Disease Diagnostics Testing Products, Services and Solutions
5.6.4 Becton, Dickinson and Company Infectious Disease Diagnostics Testing Revenue (US$ Million) & (2018-2023)
5.6.5 Becton, Dickinson and Company Recent Developments
5.7 Bio-Rad Laboratories
5.7.1 Bio-Rad Laboratories Profile
5.7.2 Bio-Rad Laboratories Main Business
5.7.3 Bio-Rad Laboratories Infectious Disease Diagnostics Testing Products, Services and Solutions
5.7.4 Bio-Rad Laboratories Infectious Disease Diagnostics Testing Revenue (US$ Million) & (2018-2023)
5.7.5 Bio-Rad Laboratories Recent Developments
5.8 Cavidi
5.8.1 Cavidi Profile
5.8.2 Cavidi Main Business
5.8.3 Cavidi Infectious Disease Diagnostics Testing Products, Services and Solutions
5.8.4 Cavidi Infectious Disease Diagnostics Testing Revenue (US$ Million) & (2018-2023)
5.8.5 Cavidi Recent Developments
5.9 Cepheid
5.9.1 Cepheid Profile
5.9.2 Cepheid Main Business
5.9.3 Cepheid Infectious Disease Diagnostics Testing Products, Services and Solutions
5.9.4 Cepheid Infectious Disease Diagnostics Testing Revenue (US$ Million) & (2018-2023)
5.9.5 Cepheid Recent Developments
5.10 Corgenix
5.10.1 Corgenix Profile
5.10.2 Corgenix Main Business
5.10.3 Corgenix Infectious Disease Diagnostics Testing Products, Services and Solutions
5.10.4 Corgenix Infectious Disease Diagnostics Testing Revenue (US$ Million) & (2018-2023)
5.10.5 Corgenix Recent Developments
5.11 Diaxonhit
5.11.1 Diaxonhit Profile
5.11.2 Diaxonhit Main Business
5.11.3 Diaxonhit Infectious Disease Diagnostics Testing Products, Services and Solutions
5.11.4 Diaxonhit Infectious Disease Diagnostics Testing Revenue (US$ Million) & (2018-2023)
5.11.5 Diaxonhit Recent Developments
5.12 Eiken Chemical
5.12.1 Eiken Chemical Profile
5.12.2 Eiken Chemical Main Business
5.12.3 Eiken Chemical Infectious Disease Diagnostics Testing Products, Services and Solutions
5.12.4 Eiken Chemical Infectious Disease Diagnostics Testing Revenue (US$ Million) & (2018-2023)
5.12.5 Eiken Chemical Recent Developments
5.13 EMD Millipore
5.13.1 EMD Millipore Profile
5.13.2 EMD Millipore Main Business
5.13.3 EMD Millipore Infectious Disease Diagnostics Testing Products, Services and Solutions
5.13.4 EMD Millipore Infectious Disease Diagnostics Testing Revenue (US$ Million) & (2018-2023)
5.13.5 EMD Millipore Recent Developments
5.14 Epitope Diagnostic
5.14.1 Epitope Diagnostic Profile
5.14.2 Epitope Diagnostic Main Business
5.14.3 Epitope Diagnostic Infectious Disease Diagnostics Testing Products, Services and Solutions
5.14.4 Epitope Diagnostic Infectious Disease Diagnostics Testing Revenue (US$ Million) & (2018-2023)
5.14.5 Epitope Diagnostic Recent Developments
5.15 EUROIMMUN
5.15.1 EUROIMMUN Profile
5.15.2 EUROIMMUN Main Business
5.15.3 EUROIMMUN Infectious Disease Diagnostics Testing Products, Services and Solutions
5.15.4 EUROIMMUN Infectious Disease Diagnostics Testing Revenue (US$ Million) & (2018-2023)
5.15.5 EUROIMMUN Recent Developments
5.16 Gold Standard Diagnostics
5.16.1 Gold Standard Diagnostics Profile
5.16.2 Gold Standard Diagnostics Main Business
5.16.3 Gold Standard Diagnostics Infectious Disease Diagnostics Testing Products, Services and Solutions
5.16.4 Gold Standard Diagnostics Infectious Disease Diagnostics Testing Revenue (US$ Million) & (2018-2023)
5.16.5 Gold Standard Diagnostics Recent Developments
5.17 Hologic
5.17.1 Hologic Profile
5.17.2 Hologic Main Business
5.17.3 Hologic Infectious Disease Diagnostics Testing Products, Services and Solutions
5.17.4 Hologic Infectious Disease Diagnostics Testing Revenue (US$ Million) & (2018-2023)
5.17.5 Hologic Recent Developments
5.18 Immunetics
5.18.1 Immunetics Profile
5.18.2 Immunetics Main Business
5.18.3 Immunetics Infectious Disease Diagnostics Testing Products, Services and Solutions
5.18.4 Immunetics Infectious Disease Diagnostics Testing Revenue (US$ Million) & (2018-2023)
5.18.5 Immunetics Recent Developments
5.19 InBios International
5.19.1 InBios International Profile
5.19.2 InBios International Main Business
5.19.3 InBios International Infectious Disease Diagnostics Testing Products, Services and Solutions
5.19.4 InBios International Infectious Disease Diagnostics Testing Revenue (US$ Million) & (2018-2023)
5.19.5 InBios International Recent Developments
6 North America
6.1 North America Infectious Disease Diagnostics Testing Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Infectious Disease Diagnostics Testing Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Infectious Disease Diagnostics Testing Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Infectious Disease Diagnostics Testing Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Infectious Disease Diagnostics Testing Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Infectious Disease Diagnostics Testing Market Dynamics
11.1 Infectious Disease Diagnostics Testing Industry Trends
11.2 Infectious Disease Diagnostics Testing Market Drivers
11.3 Infectious Disease Diagnostics Testing Market Challenges
11.4 Infectious Disease Diagnostics Testing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
List of Tables
    Table 1. Global Market Infectious Disease Diagnostics Testing Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029
    Table 2. Global Infectious Disease Diagnostics Testing Market Size by Region (2018-2023) & (US$ Million)
    Table 3. Global Infectious Disease Diagnostics Testing Market Size Share by Region (2018-2023)
    Table 4. Global Infectious Disease Diagnostics Testing Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 5. Global Infectious Disease Diagnostics Testing Forecasted Market Size Share by Region (2024-2029)
    Table 6. Global Infectious Disease Diagnostics Testing Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029
    Table 7. Global Infectious Disease Diagnostics Testing Market Size by Type (2018-2023) & (US$ Million)
    Table 8. Global Infectious Disease Diagnostics Testing Revenue Market Share by Type (2018-2023)
    Table 9. Global Infectious Disease Diagnostics Testing Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 10. Global Infectious Disease Diagnostics Testing Revenue Market Share by Type (2024-2029)
    Table 11. North America Infectious Disease Diagnostics Testing Revenue by Type (2018-2023) & (US$ Million)
    Table 12. North America Infectious Disease Diagnostics Testing Revenue by Type (2024-2029) & (US$ Million)
    Table 13. Europe Infectious Disease Diagnostics Testing Revenue by Type (2018-2023) & (US$ Million)
    Table 14. Europe Infectious Disease Diagnostics Testing Revenue by Type (2024-2029) & (US$ Million)
    Table 15. Asia-Pacific Infectious Disease Diagnostics Testing Revenue by Type (2018-2023) & (US$ Million)
    Table 16. Asia-Pacific Infectious Disease Diagnostics Testing Revenue by Type (2024-2029) & (US$ Million)
    Table 17. Latin America Infectious Disease Diagnostics Testing Revenue by Type (2018-2023) & (US$ Million)
    Table 18. Latin America Infectious Disease Diagnostics Testing Revenue by Type (2024-2029) & (US$ Million)
    Table 19. Middle East and Africa Infectious Disease Diagnostics Testing Revenue by Type (2018-2023) & (US$ Million)
    Table 20. Middle East and Africa Infectious Disease Diagnostics Testing Revenue by Type (2024-2029) & (US$ Million)
    Table 21. Global Infectious Disease Diagnostics Testing Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029
    Table 22. Global Infectious Disease Diagnostics Testing Market Size by Application (2018-2023) & (US$ Million)
    Table 23. Global Infectious Disease Diagnostics Testing Revenue Market Share by Application (2018-2023)
    Table 24. Global Infectious Disease Diagnostics Testing Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 25. Global Infectious Disease Diagnostics Testing Revenue Market Share by Application (2024-2029)
    Table 26. North America Infectious Disease Diagnostics Testing Revenue by Application (2018-2023) & (US$ Million)
    Table 27. North America Infectious Disease Diagnostics Testing Revenue by Application (2024-2029) & (US$ Million)
    Table 28. Europe Infectious Disease Diagnostics Testing Revenue by Application (2018-2023) & (US$ Million)
    Table 29. Europe Infectious Disease Diagnostics Testing Revenue by Application (2024-2029) & (US$ Million)
    Table 30. Asia-Pacific Infectious Disease Diagnostics Testing Revenue by Application (2018-2023) & (US$ Million)
    Table 31. Asia-Pacific Infectious Disease Diagnostics Testing Revenue by Application (2024-2029) & (US$ Million)
    Table 32. Latin America Infectious Disease Diagnostics Testing Revenue by Application (2018-2023) & (US$ Million)
    Table 33. Latin America Infectious Disease Diagnostics Testing Revenue by Application (2024-2029) & (US$ Million)
    Table 34. Middle East and Africa Infectious Disease Diagnostics Testing Revenue by Application (2018-2023) & (US$ Million)
    Table 35. Middle East and Africa Infectious Disease Diagnostics Testing Revenue by Application (2024-2029) & (US$ Million)
    Table 36. Global Infectious Disease Diagnostics Testing Revenue (US$ Million) by Players (2018-2023)
    Table 37. Global Infectious Disease Diagnostics Testing Revenue Market Share by Players (2018-2023)
    Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Infectious Disease Diagnostics Testing as of 2022)
    Table 39. Date of Key Players Enter into Infectious Disease Diagnostics Testing Market
    Table 40. Global Infectious Disease Diagnostics Testing Key Players Headquarters and Area Served
    Table 41. Infectious Disease Diagnostics Testing Product Solution and Service
    Table 42. Global Infectious Disease Diagnostics Testing Players Market Concentration Ratio (CR5 and HHI)
    Table 43. Mergers & Acquisitions, Expansion Plans
    Table 44. Abbott Basic Information List
    Table 45. Abbott Description and Business Overview
    Table 46. Abbott Infectious Disease Diagnostics Testing Products, Services and Solutions
    Table 47. Revenue (US$ Million) in Infectious Disease Diagnostics Testing Business of Abbott (2018-2023)
    Table 48. Abbott Recent Developments
    Table 49. bioMérieux Basic Information List
    Table 50. bioMérieux Description and Business Overview
    Table 51. bioMérieux Infectious Disease Diagnostics Testing Products, Services and Solutions
    Table 52. Revenue (US$ Million) in Infectious Disease Diagnostics Testing Business of bioMérieux (2018-2023)
    Table 53. bioMérieux Recent Developments
    Table 54. Diasorin Basic Information List
    Table 55. Diasorin Description and Business Overview
    Table 56. Diasorin Infectious Disease Diagnostics Testing Products, Services and Solutions
    Table 57. Revenue (US$ Million) in Infectious Disease Diagnostics Testing Business of Diasorin (2018-2023)
    Table 58. Diasorin Recent Developments
    Table 59. Roche Diagnostic Basic Information List
    Table 60. Roche Diagnostic Description and Business Overview
    Table 61. Roche Diagnostic Infectious Disease Diagnostics Testing Products, Services and Solutions
    Table 62. Revenue (US$ Million) in Infectious Disease Diagnostics Testing Business of Roche Diagnostic (2018-2023)
    Table 63. Roche Diagnostic Recent Developments
    Table 64. Beckman Coulter Basic Information List
    Table 65. Beckman Coulter Description and Business Overview
    Table 66. Beckman Coulter Infectious Disease Diagnostics Testing Products, Services and Solutions
    Table 67. Revenue (US$ Million) in Infectious Disease Diagnostics Testing Business of Beckman Coulter (2018-2023)
    Table 68. Beckman Coulter Recent Developments
    Table 69. Becton, Dickinson and Company Basic Information List
    Table 70. Becton, Dickinson and Company Description and Business Overview
    Table 71. Becton, Dickinson and Company Infectious Disease Diagnostics Testing Products, Services and Solutions
    Table 72. Revenue (US$ Million) in Infectious Disease Diagnostics Testing Business of Becton, Dickinson and Company (2018-2023)
    Table 73. Becton, Dickinson and Company Recent Developments
    Table 74. Bio-Rad Laboratories Basic Information List
    Table 75. Bio-Rad Laboratories Description and Business Overview
    Table 76. Bio-Rad Laboratories Infectious Disease Diagnostics Testing Products, Services and Solutions
    Table 77. Revenue (US$ Million) in Infectious Disease Diagnostics Testing Business of Bio-Rad Laboratories (2018-2023)
    Table 78. Bio-Rad Laboratories Recent Developments
    Table 79. Cavidi Basic Information List
    Table 80. Cavidi Description and Business Overview
    Table 81. Cavidi Infectious Disease Diagnostics Testing Products, Services and Solutions
    Table 82. Revenue (US$ Million) in Infectious Disease Diagnostics Testing Business of Cavidi (2018-2023)
    Table 83. Cavidi Recent Developments
    Table 84. Cepheid Basic Information List
    Table 85. Cepheid Description and Business Overview
    Table 86. Cepheid Infectious Disease Diagnostics Testing Products, Services and Solutions
    Table 87. Revenue (US$ Million) in Infectious Disease Diagnostics Testing Business of Cepheid (2018-2023)
    Table 88. Cepheid Recent Developments
    Table 89. Corgenix Basic Information List
    Table 90. Corgenix Description and Business Overview
    Table 91. Corgenix Infectious Disease Diagnostics Testing Products, Services and Solutions
    Table 92. Revenue (US$ Million) in Infectious Disease Diagnostics Testing Business of Corgenix (2018-2023)
    Table 93. Corgenix Recent Developments
    Table 94. Diaxonhit Basic Information List
    Table 95. Diaxonhit Description and Business Overview
    Table 96. Diaxonhit Infectious Disease Diagnostics Testing Products, Services and Solutions
    Table 97. Revenue (US$ Million) in Infectious Disease Diagnostics Testing Business of Diaxonhit (2018-2023)
    Table 98. Diaxonhit Recent Developments
    Table 99. Eiken Chemical Basic Information List
    Table 100. Eiken Chemical Description and Business Overview
    Table 101. Eiken Chemical Infectious Disease Diagnostics Testing Products, Services and Solutions
    Table 102. Revenue (US$ Million) in Infectious Disease Diagnostics Testing Business of Eiken Chemical (2018-2023)
    Table 103. Eiken Chemical Recent Developments
    Table 104. EMD Millipore Basic Information List
    Table 105. EMD Millipore Description and Business Overview
    Table 106. EMD Millipore Infectious Disease Diagnostics Testing Products, Services and Solutions
    Table 107. Revenue (US$ Million) in Infectious Disease Diagnostics Testing Business of EMD Millipore (2018-2023)
    Table 108. EMD Millipore Recent Developments
    Table 109. Epitope Diagnostic Basic Information List
    Table 110. Epitope Diagnostic Description and Business Overview
    Table 111. Epitope Diagnostic Infectious Disease Diagnostics Testing Products, Services and Solutions
    Table 112. Revenue (US$ Million) in Infectious Disease Diagnostics Testing Business of Epitope Diagnostic (2018-2023)
    Table 113. Epitope Diagnostic Recent Developments
    Table 114. EUROIMMUN Basic Information List
    Table 115. EUROIMMUN Description and Business Overview
    Table 116. EUROIMMUN Infectious Disease Diagnostics Testing Products, Services and Solutions
    Table 117. Revenue (US$ Million) in Infectious Disease Diagnostics Testing Business of EUROIMMUN (2018-2023)
    Table 118. EUROIMMUN Recent Developments
    Table 119. Gold Standard Diagnostics Basic Information List
    Table 120. Gold Standard Diagnostics Description and Business Overview
    Table 121. Gold Standard Diagnostics Infectious Disease Diagnostics Testing Products, Services and Solutions
    Table 122. Revenue (US$ Million) in Infectious Disease Diagnostics Testing Business of Gold Standard Diagnostics (2018-2023)
    Table 123. Gold Standard Diagnostics Recent Developments
    Table 124. Hologic Basic Information List
    Table 125. Hologic Description and Business Overview
    Table 126. Hologic Infectious Disease Diagnostics Testing Products, Services and Solutions
    Table 127. Revenue (US$ Million) in Infectious Disease Diagnostics Testing Business of Hologic (2018-2023)
    Table 128. Hologic Recent Developments
    Table 129. Immunetics Basic Information List
    Table 130. Immunetics Description and Business Overview
    Table 131. Immunetics Infectious Disease Diagnostics Testing Products, Services and Solutions
    Table 132. Revenue (US$ Million) in Infectious Disease Diagnostics Testing Business of Immunetics (2018-2023)
    Table 133. Immunetics Recent Developments
    Table 134. InBios International Basic Information List
    Table 135. InBios International Description and Business Overview
    Table 136. InBios International Infectious Disease Diagnostics Testing Products, Services and Solutions
    Table 137. Revenue (US$ Million) in Infectious Disease Diagnostics Testing Business of InBios International (2018-2023)
    Table 138. InBios International Recent Developments
    Table 139. North America Infectious Disease Diagnostics Testing Market Size by Country (2018-2023) & (US$ Million)
    Table 140. North America Infectious Disease Diagnostics Testing Market Size by Country (2024-2029) & (US$ Million)
    Table 141. Europe Infectious Disease Diagnostics Testing Market Size by Country (2018-2023) & (US$ Million)
    Table 142. Europe Infectious Disease Diagnostics Testing Market Size by Country (2024-2029) & (US$ Million)
    Table 143. Asia-Pacific Infectious Disease Diagnostics Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 144. Asia-Pacific Infectious Disease Diagnostics Testing Market Size by Region (2018-2023) & (US$ Million)
    Table 145. Asia-Pacific Infectious Disease Diagnostics Testing Market Size by Region (2024-2029) & (US$ Million)
    Table 146. Asia-Pacific Infectious Disease Diagnostics Testing Market Share by Region (2018-2023)
    Table 147. Asia-Pacific Infectious Disease Diagnostics Testing Market Share by Region (2024-2029)
    Table 148. Latin America Infectious Disease Diagnostics Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 149. Latin America Infectious Disease Diagnostics Testing Market Size by Country (2018-2023) & (US$ Million)
    Table 150. Latin America Infectious Disease Diagnostics Testing Market Size by Country (2024-2029) & (US$ Million)
    Table 151. Middle East & Africa Infectious Disease Diagnostics Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 152. Middle East & Africa Infectious Disease Diagnostics Testing Market Size by Country (2018-2023) & (US$ Million)
    Table 153. Middle East & Africa Infectious Disease Diagnostics Testing Market Size by Country (2024-2029) & (US$ Million)
    Table 154. Infectious Disease Diagnostics Testing Market Trends
    Table 155. Infectious Disease Diagnostics Testing Market Drivers
    Table 156. Infectious Disease Diagnostics Testing Market Challenges
    Table 157. Infectious Disease Diagnostics Testing Market Restraints
    Table 158. Research Programs/Design for This Report
    Table 159. Key Data Information from Secondary Sources
    Table 160. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Infectious Disease Diagnostics Testing Market Size Year-over-Year 2018-2029 & (US$ Million)
    Figure 2. Global Infectious Disease Diagnostics Testing Market Size (US$ Million), 2018 VS 2022 VS 2029
    Figure 3. Global Infectious Disease Diagnostics Testing Market Share by Regions: 2022 VS 2029
    Figure 4. Global Infectious Disease Diagnostics Testing Forecasted Market Size Share by Region (2024-2029)
    Figure 5. North America Infectious Disease Diagnostics Testing Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 6. Europe Infectious Disease Diagnostics Testing Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 7. Asia-Pacific Infectious Disease Diagnostics Testing Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 8. Latin America Infectious Disease Diagnostics Testing Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 9. Middle East & Africa Infectious Disease Diagnostics Testing Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 10. Product Picture of Molecular Diagnostic Test
    Figure 11. Global Molecular Diagnostic Test Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 12. Product Picture of POC Infectious Disease Diagnostics Test
    Figure 13. Global POC Infectious Disease Diagnostics Test Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 14. Global Infectious Disease Diagnostics Testing Market Size Share by Type: 2022 & 2029
    Figure 15. North America Infectious Disease Diagnostics Testing Revenue Market Share by Type (2018-2029)
    Figure 16. Europe Infectious Disease Diagnostics Testing Revenue Market Share by Type (2018-2029)
    Figure 17. Asia-Pacific Infectious Disease Diagnostics Testing Revenue Market Share by Type (2018-2029)
    Figure 18. Latin America Infectious Disease Diagnostics Testing Revenue Market Share by Type (2018-2029)
    Figure 19. Middle East and Africa Infectious Disease Diagnostics Testing Revenue Market Share by Type (2018-2029)
    Figure 20. Hospital Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 21. Academics Research Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 22. Others Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 23. Global Infectious Disease Diagnostics Testing Market Size Share by Application: 2022 & 2029
    Figure 24. North America Infectious Disease Diagnostics Testing Revenue Market Share by Application (2018-2029)
    Figure 25. Europe Infectious Disease Diagnostics Testing Revenue Market Share by Application (2018-2029)
    Figure 26. Asia-Pacific Infectious Disease Diagnostics Testing Revenue Market Share by Application (2018-2029)
    Figure 27. Latin America Infectious Disease Diagnostics Testing Revenue Market Share by Application (2018-2029)
    Figure 28. Middle East and Africa Infectious Disease Diagnostics Testing Revenue Market Share by Application (2018-2029)
    Figure 29. Infectious Disease Diagnostics Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
    Figure 30. Global Top 5 and Top 10 Players Infectious Disease Diagnostics Testing Market Share in 2022
    Figure 31. North America Infectious Disease Diagnostics Testing Market Share by Country (2018-2029)
    Figure 32. U.S. Infectious Disease Diagnostics Testing Market Size (2018-2029) & (US$ Million)
    Figure 33. Canada Infectious Disease Diagnostics Testing Market Size (2018-2029) & (US$ Million)
    Figure 34. Germany Infectious Disease Diagnostics Testing Market Size (2018-2029) & (US$ Million)
    Figure 35. France Infectious Disease Diagnostics Testing Market Size (2018-2029) & (US$ Million)
    Figure 36. U.K. Infectious Disease Diagnostics Testing Market Size (2018-2029) & (US$ Million)
    Figure 37. Italy Infectious Disease Diagnostics Testing Market Size (2018-2029) & (US$ Million)
    Figure 38. Russia Infectious Disease Diagnostics Testing Market Size (2018-2029) & (US$ Million)
    Figure 39. Nordic Countries Infectious Disease Diagnostics Testing Market Size (2018-2029) & (US$ Million)
    Figure 40. Asia-Pacific Infectious Disease Diagnostics Testing Market Share by Region (2018-2029)
    Figure 41. China Infectious Disease Diagnostics Testing Market Size (2018-2029) & (US$ Million)
    Figure 42. Japan Infectious Disease Diagnostics Testing Market Size (2018-2029) & (US$ Million)
    Figure 43. South Korea Infectious Disease Diagnostics Testing Market Size (2018-2029) & (US$ Million)
    Figure 44. Southeast Asia Infectious Disease Diagnostics Testing Market Size (2018-2029) & (US$ Million)
    Figure 45. India Infectious Disease Diagnostics Testing Market Size (2018-2029) & (US$ Million)
    Figure 46. Australia Infectious Disease Diagnostics Testing Market Size (2018-2029) & (US$ Million)
    Figure 47. Latin America Infectious Disease Diagnostics Testing Market Share by Country (2018-2029)
    Figure 48. Mexico Infectious Disease Diagnostics Testing Market Size (2018-2029) & (US$ Million)
    Figure 49. Brazil Infectious Disease Diagnostics Testing Market Size (2018-2029) & (US$ Million)
    Figure 50. Middle East & Africa Infectious Disease Diagnostics Testing Market Share by Country (2018-2029)
    Figure 51. Turkey Infectious Disease Diagnostics Testing Market Size (2018-2029) & (US$ Million)
    Figure 52. Saudi Arabia Infectious Disease Diagnostics Testing Market Size (2018-2029) & (US$ Million)
    Figure 53. UAE Infectious Disease Diagnostics Testing Market Size (2018-2029) & (US$ Million)
    Figure 54. Bottom-up and Top-down Approaches for This Report
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3350

This license allows only one user to access the PDF.
Electronic (PDF)

$5025

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$6700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network